Page last updated: 2024-09-04

moxifloxacin and amikacin

moxifloxacin has been researched along with amikacin in 59 studies

Compound Research Comparison

Studies (moxifloxacin)	Trials (moxifloxacin)	Recent Studies (post-2010) (moxifloxacin)	Studies (amikacin)	Trials (amikacin)	Recent Studies (post-2010) (amikacin)
3,157	552	1,690	4,739	485	1,316

Research

Studies (59)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	10 (16.95)	29.6817
2010's	28 (47.46)	24.3611
2020's	21 (35.59)	2.80

Authors

Authors	Studies
Bouza, E; Cercenado, E; Cuevas, O; Marín, M; Martínez-Alarcón, J; Sánchez-Martínez, M	1
Cho, SH; Franzblau, SG; Hwang, CH; Pauli, GF; Wan, B; Warit, S	1
Courvalin, P; Galimand, M; Périchon, B	1
Andres, P; Centrón, D; Galas, M; Guerriero, L; Petroni, A; Quiroga, C; Quiroga, MP; Soler Bistué, AJ; Tokumoto, M; Tolmasky, ME; Vargas, LJ; Zorreguieta, A	1
Baudry, PJ; DeCorby, M; Hoban, DJ; Johnson, J; Karlowsky, JA; Lagacé-Wiens, P; Laing, N; McCracken, M; Mulvey, MR; Nichol, KA; Tailor, F; Vashisht, R; Walkty, A; Weshnoweski, B; Wierzbowski, A; Zhanel, GG	1
Lombardo, F; Obach, RS; Waters, NJ	1
Cattoir, V; Nordmann, P; Poirel, L	1
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A	1
Barber, M; Eberly, LE; Feeney, LA; Miller, GH; Summers, A; Wortmann, G; Zapor, MJ	1
Khanna, A; Pareek, PK; Raj, VS; Rattan, A; Saini, KS; Sharma, P; Singh, H; Sood, R; Tarai, B; Upadhyay, DJ	1
Hamprecht, A; Higgins, PG; Schneiders, T; Seifert, H	1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K	1
Fernando, DM; Gorityala, BK; Goswami, S; Guchhait, G; Kumar, A; Schweizer, F; Zhanel, GG	1
Domalaon, R; Gorityala, BK; Goswami, S; Idowu, T; Lyu, Y; Schweizer, F; Shan, A; Yang, X; Zhanel, GG	1
da Silva Emery, F; de Melo, SMG; Fumagalli, F; Pavan, FR; Ribeiro, CM; Solcia, MC	1
Bishai, WR; Duan, G; Gunosewoyo, H; Liu, LL; Lun, S; Tang, J; Xiao, S; Yang, F; Yu, LF; Zhang, W	1
Alonso-Rodriguez, N; Briffotaux, J; Buchieri, MV; Cimino, M; Coulibaly, S; Dallemagne, P; Gicquel, B; Lecoutey, C; Mornico, D; Ouattara, M; Rochais, C	1
Bano, G; Castagnolo, D; Chibale, K; Gianibbi, B; Manetti, F; Pavan, FR; Pisano, L; Ribeiro, CM; Semenya, D; Singh, V; Toscani, A; Touitou, M	1
Castagnolo, D; Dos Santos Fernandes, GF; Gianibbi, B; Manetti, F; Masci, D; Pavan, FR; Ribeiro, CM; Semenya, D; Touitou, M	1
Chauffour, A; Jarlier, V; Ji, B; Lefrançois, S; Robert, J; Truffot, C	1
Dahan, K; Delahousse, M; El Kabbaj, D; Pastural, M; Venditto, M	1
Espandar, L; Meyer, JJ; Moshirfar, M	1
Fattorini, L; Filippini, P; Iona, E; Neyrolles, O; Peyron, P; Piccaro, G	1
Pacheco, PA; Tam, PM	1
Huang, FC; Shih, MH	1
Bae, SM; Cheong, HJ; Choi, WS; Kim, MJ; Park, DW; Sohn, JW; Son, SW; Song, T; Yoon, YK	1
Girgis, DO; Karp, CL; Miller, D	1
Aarnoutse, RE; Bakker-Woudenberg, IA; Boeree, MJ; de Knegt, GJ; de Steenwinkel, JE; Kremer, K; ten Kate, MT; van Soolingen, D; Verbrugh, HA	1
Aubry, A; Brossier, F; Chauffour, A; Fillion, A; Jarlier, V; Veziris, N	1
Gratz, J; Heysell, SK; Houpt, ER; Kibiki, GS; Kumburu, H; Mpagama, SG; Ndusilo, N; Peloquin, CA; Stroup, S	1
Ajbani, K; Catanzaro, A; Caviedes, L; Coronel, J; Crudu, V; Desmond, E; Eisenach, K; Ganiats, TG; Garfein, RS; Groessl, EJ; Jackson, RL; Klages, S; Moore, D; Rodrigues, C; Rodwell, TC; Romancenco, E; Trollip, AP; Victor, T; Vineet, VP	1
de Droogh, E; Groenen, G; Mathys, V; Soetaert, K; van de Vyvere, M	1
Blackmore, T; McNaughton, A; McNaughton, H	1
Al-Hajoj, S; Varghese, B	1
Lu, J; Pang, Y; Song, Y; Zhang, Z	1
Akkerman, OW; Bathoorn, E; de Lange, WCM; Lokate, M; Louka, C; Pournaras, S; Ravensbergen, SJ; Stienstra, Y; van der Werf, TS	1
Kim, EK; Kim, SK; Kim, TI; Ko, J; Yong, DE	1
Aguilar-Ayala, DA; Cnockaert, M; Gonzalez-Y-Merchand, J; Martin, A; Palomino, JC; Vandamme, P	1
Chen, WL; Chu, HS; Hu, FR; Liu, HY; Wang, IJ	1
Ahmad, N; Ahuja, SD; Akkerman, OW; Alffenaar, JC; Anderson, LF; Baghaei, P; Bang, D; Barry, PM; Bastos, ML; Behera, D; Benedetti, A; Bisson, GP; Boeree, MJ; Bonnet, M; Brode, SK; Brust, JCM; Cai, Y; Caumes, E; Cegielski, JP; Centis, R; Chan, ED; Chan, PC; Chang, KC; Charles, M; Cirule, A; D'Ambrosio, L; Dalcolmo, MP; de Vries, G; Dheda, K; Esmail, A; Flood, J; Fox, GJ; Fréchet-Jachym, M; Fregona, G; Gayoso, R; Gegia, M; Gler, MT; Gu, S; Guglielmetti, L; Holtz, TH; Hughes, J; Isaakidis, P; Jarlsberg, L; Kempker, RR; Keshavjee, S; Khan, FA; Kipiani, M; Koenig, SP; Koh, WJ; Kritski, A; Kuksa, L; Kvasnovsky, CL; Kwak, N; Lan, Z; Lange, C; Laniado-Laborín, R; Lee, M; Leimane, V; Leung, CC; Leung, EC; Li, PZ; Lowenthal, P; Maciel, EL; Marks, SM; Mase, S; Mbuagbaw, L; Menzies, D; Migliori, GB; Milanov, V; Miller, AC; Mitnick, CD; Modongo, C; Mohr, E; Monedero, I; Nahid, P; Ndjeka, N; O'Donnell, MR; Padayatchi, N; Palmero, D; Pape, JW; Podewils, LJ; Reynolds, I; Riekstina, V; Robert, J; Rodriguez, M; Schnippel, K; Seaworth, B; Seung, KJ; Shim, TS; Singla, R; Smith, SE; Sotgiu, G; Sukhbaatar, G; Tabarsi, P; Tiberi, S; Trajman, A; Trieu, L; Udwadia, ZF; van der Werf, TS; Veziris, N; Viiklepp, P; Vilbrun, SC; Walsh, K; Westenhouse, J; Yew, WW; Yim, JJ; Zetola, NM; Zignol, M	1
Andersen, ÅB; Gynthersen, R; Katzenstein, TL; Qvist, T	1
Fukui, M; Marumo, S; Shirata, M; Tamai, K; Yoshimoto, Y	1
Chang, CL; Chen, LC; Chien, JY; Hsueh, PR; Yu, CJ	1
Chonan, M; Fujimoto, Y; Ihara, H; Iwai, M; Kurokawa, K; Misawa, S; Nakamura, A; Ochi, Y; Ohsaka, A; Okabe, T; Shibayama, K; Sumiyoshi, I; Takahashi, K; Takei, S; Togo, S; Watanabe, J	1
Chen, J; Chen, X; He, G; Lin, S; Sun, F; Wang, S; Zhang, W	1
Ahmad, N; Atif, M; Ghafoor, A; Iqbal, Q; Khan, S; Latif, A; Saleem, F; Wahid, A	1
Basdeo, SA; Cahill, C; Cox, DJ; Gogan, KM; Gordon, SV; Keane, J; O'Connell, F; O'Sullivan, J; Phelan, JJ	1
Khandelwal, S; Malhotra, B; Sharma, M	1
Guo, Y; Liu, H; Sha, W; Shen, H; Shen, X; Tan, G; Wu, X; Wu, Z; Yang, J; Yu, F	1
Guo, Y; Huang, C; Sha, W; Tan, G; Wu, X; Yang, J; Yu, F	1
He, W; Li, Y; Liu, C; Ma, A; Qiu, Q; Zhao, Y	1
Daneshfar, S; Hashemzadeh, M; Khosravi, AD	1
Gao, M; Guo, Y; Huo, F; Jia, J; Jiang, H; Li, W; Ma, H; Qin, L; Wu, X; Xue, Y; Yin, J; Zhu, C	1
Brankin, A; Colman, RE; Georghiou, SB; Seifert, M; Suresh, A; Uplekar, S; Walker, TM	1
Alcaide, F; Andres, S; Aubry, A; Benmansour, H; Boarbi, S; Cambau, E; Chryssanthou, E; Cirillo, DM; Fernström, L; Fitzgibbon, MM; Fröberg, G; Giske, CG; Hyyryläinen, HL; Kahlmeter, G; Keller, PM; Machado, D; Maurer, FP; Mengshoel, AT; Mok, S; Nadarajan, D; Schön, T; Svensson, E; Turnidge, J; van Ingen, J; Viveiros, M; Werngren, J	1
Arslan, N; Esen, N; Özkarataş, MH; Özkütük, AA	1
Berge, I; Bogdanova, I; Freimane, L; Norvaiša, I; Ozere, I; Ranka, R; Sadovska, D; Vaivode, A; Vīksna, A	1
Adeel, A; Ahmad, A; Ahmad, I; Aslam, H; Mushtaq, F; Raza, SM; Saleem, S	1
Faksri, K; Hinwan, Y; Kaewprasert, O; Sirichoat, A	1

Reviews

4 review(s) available for moxifloxacin and amikacin

Article	Year
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans. Drug discovery today, 2016, Volume: 21, Issue:4 Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk	2016
Delayed onset Mycobacterium intracellulare keratitis after laser in situ keratomileusis: A case report and literature review. Medicine, 2017, Volume: 96, Issue:51 Topics: Administration, Topical; Adult; Amikacin; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Eye Infections, Bacterial; Fluoroquinolones; Follow-Up Studies; Humans; Keratitis; Keratomileusis, Laser In Situ; Male; Moxifloxacin; Mycobacterium avium Complex; Severity of Illness Index; Treatment Outcome	2017
Bilateral Non-tuberculous Mycobacterial Keratitis After Small Incision Lenticule Extraction. Journal of refractive surgery (Thorofare, N.J. : 1995), 2018, Sep-01, Volume: 34, Issue:9 Topics: Administration, Ophthalmic; Administration, Oral; Amikacin; Anti-Bacterial Agents; Clarithromycin; Corneal Surgery, Laser; Corneal Ulcer; Drug Therapy, Combination; Eye Infections, Bacterial; Female; Fluoroquinolones; Humans; Imipenem; Microsurgery; Moxifloxacin; Mycobacterium abscessus; Mycobacterium Infections, Nontuberculous; Myopia; Refraction, Ocular; Surgical Flaps; Tomography, Optical Coherence; Visual Acuity; Young Adult	2018
Treatment correlates of successful outcomes in pulmonary multidrug-resistant tuberculosis: an individual patient data meta-analysis. Lancet (London, England), 2018, 09-08, Volume: 392, Issue:10150 Topics: Amikacin; Antitubercular Agents; Capreomycin; Carbapenems; Clofazimine; Diarylquinolines; Drug Therapy, Combination; Fluoroquinolones; Humans; Kanamycin; Levofloxacin; Linezolid; Moxifloxacin; Recurrence; Treatment Failure; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary	2018

Other Studies

55 other study(ies) available for moxifloxacin and amikacin

Article	Year
In vitro activities of tigecycline and eight other antimicrobials against different Nocardia species identified by molecular methods. Antimicrobial agents and chemotherapy, 2007, Volume: 51, Issue:3 Topics: Anti-Bacterial Agents; Humans; Microbial Sensitivity Tests; Minocycline; Nocardia; Nocardia Infections; Polymorphism, Restriction Fragment Length; Reverse Transcriptase Polymerase Chain Reaction; Tigecycline	2007
Low-oxygen-recovery assay for high-throughput screening of compounds against nonreplicating Mycobacterium tuberculosis. Antimicrobial agents and chemotherapy, 2007, Volume: 51, Issue:4 Topics: Anti-Bacterial Agents; Antitubercular Agents; DNA, Bacterial; Drug Evaluation, Preclinical; Mycobacterium tuberculosis; Oxygen	2007
Transferable resistance to aminoglycosides by methylation of G1405 in 16S rRNA and to hydrophilic fluoroquinolones by QepA-mediated efflux in Escherichia coli. Antimicrobial agents and chemotherapy, 2007, Volume: 51, Issue:7 Topics: Amino Acid Motifs; Amino Acid Sequence; Aminoglycosides; Anti-Bacterial Agents; Anti-Infective Agents; Conjugation, Genetic; Conserved Sequence; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Escherichia coli; Escherichia coli Proteins; Fluoroquinolones; Genes, rRNA; Methylation; Methyltransferases; Microbial Sensitivity Tests; Molecular Sequence Data; Norfloxacin; Plasmids; Sequence Analysis, DNA; Sequence Homology, Amino Acid	2007
Complex class 1 integrons with diverse variable regions, including aac(6')-Ib-cr, and a novel allele, qnrB10, associated with ISCR1 in clinical enterobacterial isolates from Argentina. Antimicrobial agents and chemotherapy, 2007, Volume: 51, Issue:12 Topics: Alleles; Amino Acid Sequence; Argentina; Bacterial Proteins; Base Sequence; beta-Lactamases; Cross Infection; DNA Transposable Elements; Drug Resistance, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Integrons; Microbial Sensitivity Tests; Molecular Sequence Data; Polymerase Chain Reaction; Sequence Analysis, DNA; Sequence Homology, Nucleic Acid	2007
Antimicrobial-resistant pathogens in intensive care units in Canada: results of the Canadian National Intensive Care Unit (CAN-ICU) study, 2005-2006. Antimicrobial agents and chemotherapy, 2008, Volume: 52, Issue:4 Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; beta-Lactamases; Canada; Drug Resistance, Bacterial; Female; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Intensive Care Units; Male; Microbial Sensitivity Tests; Middle Aged; Population Surveillance	2008
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds. Drug metabolism and disposition: the biological fate of chemicals, 2008, Volume: 36, Issue:7 Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding	2008
Plasmid-mediated quinolone resistance pump QepA2 in an Escherichia coli isolate from France. Antimicrobial agents and chemotherapy, 2008, Volume: 52, Issue:10 Topics: Aged; Base Sequence; DNA Primers; DNA, Bacterial; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Female; Fluoroquinolones; France; Genes, Bacterial; Humans; Models, Genetic; Molecular Sequence Data; Plasmids	2008
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species. Chemical research in toxicology, 2010, Volume: 23, Issue:1 Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship	2010
In vitro activity of the aminoglycoside antibiotic arbekacin against Acinetobacter baumannii-calcoaceticus isolated from war-wounded patients at Walter Reed Army Medical Center. Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:7 Topics: Acinetobacter baumannii; Aminoglycosides; Anti-Bacterial Agents; Carbapenems; Dibekacin; Hospitals, Military; Humans; Microbial Sensitivity Tests; Warfare	2010
Emergence and molecular characterization of extensively drug-resistant Mycobacterium tuberculosis clinical isolates from the Delhi Region in India. Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:11 Topics: Amikacin; Antitubercular Agents; Bacterial Proteins; Capreomycin; DNA Gyrase; DNA Mutational Analysis; DNA-Directed RNA Polymerases; Extensively Drug-Resistant Tuberculosis; Fluoroquinolones; India; Isoniazid; Kanamycin; Microbial Sensitivity Tests; Mutation; Mycobacterium tuberculosis; Point Mutation; Polymerase Chain Reaction; Rifampin	2010
In vivo selection of a missense mutation in adeR and conversion of the novel blaOXA-164 gene into blaOXA-58 in carbapenem-resistant Acinetobacter baumannii isolates from a hospitalized patient. Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:12 Topics: Acinetobacter baumannii; Acinetobacter Infections; Bacterial Proteins; Carbapenems; Drug Resistance, Bacterial; Fatal Outcome; Humans; Male; Middle Aged; Molecular Sequence Data; Mutation, Missense; Reverse Transcriptase Polymerase Chain Reaction	2010
Hybrid Antibiotic Overcomes Resistance in P. aeruginosa by Enhancing Outer Membrane Penetration and Reducing Efflux. Journal of medicinal chemistry, 2016, 09-22, Volume: 59, Issue:18 Topics: Anti-Bacterial Agents; Drug Resistance, Multiple, Bacterial; Fluoroquinolones; Humans; Moxifloxacin; Pseudomonas aeruginosa; Pseudomonas Infections; Tobramycin	2016
Amphiphilic Tobramycin-Lysine Conjugates Sensitize Multidrug Resistant Gram-Negative Bacteria to Rifampicin and Minocycline. Journal of medicinal chemistry, 2017, 05-11, Volume: 60, Issue:9 Topics: Anti-Bacterial Agents; Drug Resistance, Multiple, Bacterial; Gram-Negative Bacteria; Gram-Positive Bacteria; Hemolysis; Lysine; Microbial Sensitivity Tests; Minocycline; Models, Biological; Rifampin; Tobramycin	2017
Exploiting the furo[2,3-b]pyridine core against multidrug-resistant Mycobacterium tuberculosis. Bioorganic & medicinal chemistry letters, 2019, 04-15, Volume: 29, Issue:8 Topics: Amination; Antitubercular Agents; Drug Resistance, Multiple, Bacterial; Furans; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Pyridines; Structure-Activity Relationship	2019
Identification of Novel Coumestan Derivatives as Polyketide Synthase 13 Inhibitors against Mycobacterium tuberculosis. Part II. Journal of medicinal chemistry, 2019, 04-11, Volume: 62, Issue:7 Topics: Animals; Antitubercular Agents; Chlorocebus aethiops; Coumarins; Crystallography, X-Ray; Drug Resistance, Bacterial; Enzyme Inhibitors; Humans; Microbial Sensitivity Tests; Molecular Docking Simulation; Mycobacterium tuberculosis; Polyketide Synthases; Structure-Activity Relationship; Vero Cells	2019
Phenanthrolinic analogs of quinolones show antibacterial activity against M. tuberculosis. European journal of medicinal chemistry, 2020, Dec-01, Volume: 207 Topics: Antitubercular Agents; Drug Design; Drug Resistance, Bacterial; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Phenanthrolines; Quinolones	2020
Structural Rigidification of ACS medicinal chemistry letters, 2022, Jan-13, Volume: 13, Issue:1 Topics:	2022
Tapping into the antitubercular potential of 2,5-dimethylpyrroles: A structure-activity relationship interrogation. European journal of medicinal chemistry, 2022, Jul-05, Volume: 237 Topics: Animals; Antitubercular Agents; Humans; Mice; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Pyrroles; Structure-Activity Relationship	2022
In vitro and in vivo activities of rifampin, streptomycin, amikacin, moxifloxacin, R207910, linezolid, and PA-824 against Mycobacterium ulcerans. Antimicrobial agents and chemotherapy, 2006, Volume: 50, Issue:6 Topics: Acetamides; Amikacin; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Aza Compounds; Colony Count, Microbial; Diarylquinolines; Dose-Response Relationship, Drug; Female; Fluoroquinolones; Foot; In Vitro Techniques; Linezolid; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Moxifloxacin; Mycobacterium Infections, Nontuberculous; Mycobacterium ulcerans; Nitroimidazoles; Oxazolidinones; Quinolines; Rifampin; Streptomycin; Survival Analysis; Time Factors	2006
Intracranial Nocardia recurrence during fluorinated quinolones therapy. Transplant infectious disease : an official journal of the Transplantation Society, 2006, Volume: 8, Issue:3 Topics: Amikacin; Aza Compounds; Brain Abscess; Drug Combinations; Fluoroquinolones; Humans; Imipenem; Kidney Transplantation; Male; Middle Aged; Moxifloxacin; Nocardia; Nocardia Infections; Quinolines; Sulfamethizole; Trimethoprim	2006
Fourth-generation fluoroquinolone-resistant mycobacterial keratitis after laser in situ keratomileusis. Journal of cataract and refractive surgery, 2007, Volume: 33, Issue:11 Topics: Adult; Amikacin; Anti-Infective Agents; Aza Compounds; Clarithromycin; Corneal Ulcer; Doxycycline; Drug Resistance, Bacterial; Drug Therapy, Combination; Eye Infections, Bacterial; Female; Fluoroquinolones; Gatifloxacin; Humans; Keratomileusis, Laser In Situ; Microbial Sensitivity Tests; Moxifloxacin; Mycobacterium chelonae; Mycobacterium Infections, Nontuberculous; Quinolines	2007
Activity of drug combinations against dormant Mycobacterium tuberculosis. Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:6 Topics: 3T3 Cells; Adipocytes; Amikacin; Animals; Antitubercular Agents; Aza Compounds; Capreomycin; Colony Count, Microbial; Drug Combinations; Drug Resistance, Bacterial; Fluoroquinolones; Humans; In Vitro Techniques; Latent Tuberculosis; Metronidazole; Mice; Microbial Sensitivity Tests; Models, Biological; Moxifloxacin; Mycobacterium tuberculosis; Quinolines; Rifampin	2010
Oral moxifloxacin and topical amikacin for Mycobacterium abscessus keratitis after laser in situ keratomileusis. Journal of cataract and refractive surgery, 2010, Volume: 36, Issue:5 Topics: Administration, Oral; Administration, Topical; Amikacin; Anti-Bacterial Agents; Aza Compounds; Corneal Ulcer; Eye Infections, Bacterial; Female; Fluoroquinolones; Humans; Keratomileusis, Laser In Situ; Moxifloxacin; Mycobacterium Infections, Nontuberculous; Nontuberculous Mycobacteria; Postoperative Complications; Quinolines; Young Adult	2010
Effects of photodynamic therapy on rapidly growing nontuberculous mycobacteria keratitis. Investigative ophthalmology & visual science, 2011, Jan-05, Volume: 52, Issue:1 Topics: Amikacin; Animals; Anti-Infective Agents; Aza Compounds; Ciprofloxacin; Colony Count, Microbial; Corneal Ulcer; Drug Synergism; Eye Infections, Bacterial; Fluoroquinolones; Methylene Blue; Microbial Sensitivity Tests; Moxifloxacin; Mycobacterium fortuitum; Mycobacterium Infections, Nontuberculous; Photochemotherapy; Quinolines; Rabbits	2011
Clarithromycin and amikacin vs. clarithromycin and moxifloxacin for the treatment of post-acupuncture cutaneous infections due to Mycobacterium abscessus: a prospective observational study. Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2011, Volume: 17, Issue:7 Topics: Acupuncture Therapy; Amikacin; Anti-Bacterial Agents; Aza Compounds; Clarithromycin; Disease Outbreaks; Drug Therapy, Combination; Female; Fluoroquinolones; Humans; Korea; Male; Middle Aged; Moxifloxacin; Mycobacterium; Mycobacterium Infections; Prospective Studies; Quinolines; Skin Diseases, Bacterial; Time Factors; Treatment Outcome	2011
Ocular infections caused by non-tuberculous mycobacteria: update on epidemiology and management. Clinical & experimental ophthalmology, 2012, Volume: 40, Issue:5 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amikacin; Anti-Bacterial Agents; Aza Compounds; Child; Child, Preschool; Clarithromycin; Combined Modality Therapy; Corneal Ulcer; Eye Infections, Bacterial; Female; Florida; Fluoroquinolones; Humans; Incidence; Male; Microbial Sensitivity Tests; Middle Aged; Moxifloxacin; Mycobacterium Infections, Nontuberculous; Nontuberculous Mycobacteria; Ophthalmologic Surgical Procedures; Quinolines; Retrospective Studies; Risk Factors; Surgical Wound Infection; Young Adult	2012
Drug susceptibility of Mycobacterium tuberculosis Beijing genotype and association with MDR TB. Emerging infectious diseases, 2012, Volume: 18, Issue:4 Topics: Amikacin; Antitubercular Agents; Aza Compounds; Bacterial Proteins; Drug Resistance, Multiple, Bacterial; Fluoroquinolones; Genotype; Isoniazid; Microbial Sensitivity Tests; Moxifloxacin; Mutation; Mycobacterium tuberculosis; Quinolines; Rifampin; Statistics, Nonparametric; Tuberculosis, Multidrug-Resistant	2012
Impact of fluoroquinolone resistance on bactericidal and sterilizing activity of a moxifloxacin-containing regimen in murine tuberculosis. Antimicrobial agents and chemotherapy, 2013, Volume: 57, Issue:9 Topics: Amikacin; Animals; Antitubercular Agents; Aza Compounds; DNA Gyrase; Drug Administration Schedule; Drug Resistance, Bacterial; Ethionamide; Female; Fluoroquinolones; Mice; Microbial Sensitivity Tests; Moxifloxacin; Mutation; Mycobacterium tuberculosis; Ofloxacin; Quinolines; Recurrence; Rodent Diseases; Survival Analysis; Tuberculosis	2013
Plasma drug activity in patients on treatment for multidrug-resistant tuberculosis. Antimicrobial agents and chemotherapy, 2014, Volume: 58, Issue:2 Topics: Adolescent; Adult; Amikacin; Antitubercular Agents; Cycloserine; Ethionamide; Female; Fluoroquinolones; Humans; Kanamycin; Levofloxacin; Male; Microbial Sensitivity Tests; Middle Aged; Moxifloxacin; Mycobacterium tuberculosis; Ofloxacin; Pyrazinamide; Sputum; Tanzania; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary	2014
Second-line drug susceptibility breakpoints for Mycobacterium tuberculosis using the MODS assay. The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease, 2014, Volume: 18, Issue:2 Topics: Amikacin; Antitubercular Agents; Capreomycin; Drug Resistance, Multiple, Bacterial; Fluoroquinolones; Humans; India; Kanamycin; Microbial Sensitivity Tests; Microscopy; Moldova; Moxifloxacin; Mycobacterium tuberculosis; Ofloxacin; Peru; Predictive Value of Tests; Reproducibility of Results; South Africa; Sputum; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary	2014
False-positive rifampicin resistance on Xpert® MTB/RIF caused by a silent mutation in the rpoB gene. The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease, 2014, Volume: 18, Issue:10 Topics: Aged; Amikacin; Amino Acid Sequence; Antibiotics, Antitubercular; Bacterial Proteins; DNA-Directed RNA Polymerases; Drug Resistance, Multiple, Bacterial; Ethambutol; Ethionamide; Fluoroquinolones; Genotype; Humans; Isoniazid; Male; Molecular Sequence Data; Moxifloxacin; Mutation; Mycobacterium tuberculosis; Phenotype; Pyrazinamide; Rifampin; Sensitivity and Specificity; Sputum; Tuberculosis, Pulmonary	2014
Comprehensive cost of treating one patient with MDR/pre-XDR-TB in Wellington, New Zealand. The European respiratory journal, 2016, Volume: 48, Issue:4 Topics: Adult; Amikacin; Aminosalicylic Acid; Anti-Bacterial Agents; Antitubercular Agents; Bronchoscopy; Clofazimine; Depression; Drug Costs; Emigrants and Immigrants; Ethambutol; Extensively Drug-Resistant Tuberculosis; Fluoroquinolones; Health Care Costs; Humans; India; Isoniazid; Linezolid; Male; Mediastinum; Microbial Sensitivity Tests; Moxifloxacin; New Zealand; Pyrazinamide; Radiography, Thoracic; Rifampin; Schizophrenia, Paranoid; Tuberculosis, Lymph Node; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pleural; Tuberculosis, Pulmonary	2016
First Insight Into the Fluoroquinolone and Aminoglycoside Resistance of Multidrug-Resistant The American journal of tropical medicine and hygiene, 2017, Volume: 96, Issue:5 Topics: Adult; Aged; Amikacin; Antitubercular Agents; Capreomycin; Drug Resistance, Multiple, Bacterial; Extensively Drug-Resistant Tuberculosis; Female; Fluoroquinolones; Genes, Bacterial; Humans; Kanamycin; Male; Microbial Sensitivity Tests; Molecular Typing; Moxifloxacin; Mutation; Mycobacterium tuberculosis; Retrospective Studies; Risk Factors; Saudi Arabia; Tandem Repeat Sequences; Tuberculosis, Pulmonary	2017
In vitro activity between linezolid and other antimicrobial agents against Mycobacterium abscessus complex. Diagnostic microbiology and infectious disease, 2018, Volume: 90, Issue:1 Topics: Amikacin; Anti-Bacterial Agents; Cefoxitin; DNA-Directed RNA Polymerases; Drug Synergism; Drug Therapy, Combination; Fluoroquinolones; Humans; Linezolid; Microbial Sensitivity Tests; Minocycline; Moxifloxacin; Mycobacterium abscessus; Mycobacterium Infections, Nontuberculous; Tigecycline	2018
Case Report: Carbapenemase-Producing Enterobacteriaceae in an Asylum Seeker with Multidrug-Resistant Tuberculosis. The American journal of tropical medicine and hygiene, 2018, Volume: 98, Issue:2 Topics: Adult; Amikacin; Carbapenem-Resistant Enterobacteriaceae; Clofazimine; Drug Monitoring; Humans; Linezolid; Male; Moxifloxacin; Netherlands; Prevalence; Prothionamide; Refugees; Trimethoprim, Sulfamethoxazole Drug Combination; Tuberculosis, Multidrug-Resistant	2018
Antimicrobial activity against Mycobacterium tuberculosis under in vitro lipid-rich dormancy conditions. Journal of medical microbiology, 2018, Volume: 67, Issue:3 Topics: Amikacin; Anti-Bacterial Agents; Antitubercular Agents; Drug Tolerance; Fluoroquinolones; Genetic Fitness; Genotype; Humans; Lipid Metabolism; Lipids; Microbial Sensitivity Tests; Models, Biological; Moxifloxacin; Mycobacterium Infections, Nontuberculous; Mycobacterium tuberculosis; Nitroimidazoles; Rifampin	2018
Mycobacterium brisbanense lung infection facilitated by steroid induced adrenal insufficiency. APMIS : acta pathologica, microbiologica, et immunologica Scandinavica, 2019, Volume: 127, Issue:2 Topics: Adrenal Insufficiency; Adult; Amikacin; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Humans; Male; Moxifloxacin; Mycobacterium Infections, Nontuberculous; Nontuberculous Mycobacteria; Respiratory Tract Infections; Sputum	2019
In vitro efficacy of combinations of eight antimicrobial agents against Mycobacteroides abscessus complex. International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, 2020, Volume: 97 Topics: Actinomycetales Infections; Amikacin; Anti-Bacterial Agents; beta-Lactams; Clarithromycin; Doxycycline; Humans; Imipenem; Linezolid; Microbial Sensitivity Tests; Moxifloxacin; Mycobacteriaceae; Sequence Analysis, DNA	2020
Different clinical features of patients with pulmonary disease caused by various Mycobacterium avium-intracellulare complex subspecies and antimicrobial susceptibility. International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, 2020, Volume: 98 Topics: Adult; Aged; Aged, 80 and over; Amikacin; Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Bacterial; Female; Humans; Lung Diseases; Male; Microbial Sensitivity Tests; Middle Aged; Moxifloxacin; Mycobacterium avium; Mycobacterium avium-intracellulare Infection; Taiwan; Young Adult	2020
The synergetic effect of Imipenem-clarithromycin combination in the Mycobacteroides abscessus complex. BMC microbiology, 2020, 10-19, Volume: 20, Issue:1 Topics: Adult; Aged; Aged, 80 and over; Amikacin; Anti-Bacterial Agents; Clarithromycin; Drug Combinations; Drug Synergism; Female; Humans; Imipenem; Japan; Male; Microbial Sensitivity Tests; Middle Aged; Moxifloxacin; Mycobacterium abscessus; Mycobacterium Infections, Nontuberculous	2020
Analysis of Serial Multidrug-Resistant Tuberculosis Strains Causing Treatment Failure and Within-Host Evolution by Whole-Genome Sequencing. mSphere, 2020, 12-23, Volume: 5, Issue:6 Topics: Amikacin; Antitubercular Agents; China; Drug Resistance, Multiple, Bacterial; Humans; Microbial Sensitivity Tests; Moxifloxacin; Mutation; Mycobacterium tuberculosis; Retrospective Studies; Treatment Failure; Tuberculosis, Multidrug-Resistant; Whole Genome Sequencing	2020
Effectiveness of Shorter Treatment Regimen in Multidrug-Resistant Tuberculosis Patients in Pakistan: A Multicenter Retrospective Record Review. The American journal of tropical medicine and hygiene, 2021, 03-15, Volume: 104, Issue:5 Topics: Adult; Amikacin; Antitubercular Agents; Clofazimine; Drug Administration Schedule; Drug Resistance, Multiple, Bacterial; Ethambutol; Ethionamide; Female; Humans; Isoniazid; Lost to Follow-Up; Male; Middle Aged; Moxifloxacin; Mycobacterium tuberculosis; Pakistan; Pyrazinamide; Retrospective Studies; Survival Analysis; Treatment Failure; Tuberculosis, Multidrug-Resistant	2021
The Iron Chelator Desferrioxamine Increases the Efficacy of Bedaquiline in Primary Human Macrophages Infected with BCG. International journal of molecular sciences, 2021, Mar-13, Volume: 22, Issue:6 Topics: Amikacin; Antitubercular Agents; Bacterial Load; Cell Survival; Clofazimine; Cycloserine; Deferoxamine; Diarylquinolines; Drug Resistance, Bacterial; Drug Synergism; Gene Expression; Humans; Interferon-gamma; Interleukin-1beta; Interleukin-6; Iron; Iron Chelating Agents; Linezolid; Macrophages; Microbial Sensitivity Tests; Moxifloxacin; Mycobacterium bovis; Primary Cell Culture; Pyrazinamide	2021
Drug susceptibiity testing of nontuberculous mycobacteria by broth microdilution method. Indian journal of medical microbiology, 2021, Volume: 39, Issue:3 Topics: Amikacin; Anti-Bacterial Agents; Clarithromycin; Humans; India; Microbial Sensitivity Tests; Moxifloxacin; Mycobacterium Infections, Nontuberculous; Nontuberculous Mycobacteria; Rifampin	2021
Use of Whole-Genome Sequencing to Predict Microbiology spectrum, 2022, 04-27, Volume: 10, Issue:2 Topics: Amikacin; Aminosalicylic Acid; Antitubercular Agents; China; Cycloserine; Drug Resistance; Ethambutol; Ethionamide; Humans; Isoniazid; Kanamycin; Microbial Sensitivity Tests; Moxifloxacin; Mycobacterium tuberculosis; Ofloxacin; Rifampin; Streptomycin; Tuberculosis, Multidrug-Resistant	2022
Prediction of Mycobacterium tuberculosis drug resistance by nucleotide MALDI-TOF-MS. International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, 2022, Volume: 121 Topics: Amikacin; Antitubercular Agents; China; Drug Resistance; Ethambutol; Humans; Isoniazid; Kanamycin; Microbial Sensitivity Tests; Moxifloxacin; Mycobacterium tuberculosis; Nucleotides; Ofloxacin; Rifampin; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Streptomycin; Tuberculosis, Lymph Node	2022
Identification and drug susceptibility testing of the subspecies of Mycobacterium avium complex clinical isolates in mainland China. Journal of global antimicrobial resistance, 2022, Volume: 31 Topics: Amikacin; Clarithromycin; Drug Resistance, Bacterial; Humans; Microbial Sensitivity Tests; Moxifloxacin; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Mycobacterium tuberculosis; Rifabutin	2022
Drug susceptibility profiling and genetic determinants of drug resistance in Mycobacterium simiae isolates obtained from regional tuberculosis reference laboratories of Iran. PloS one, 2022, Volume: 17, Issue:8 Topics: Amikacin; Anti-Bacterial Agents; Clarithromycin; Drug Resistance; Humans; Iran; Laboratories; Microbial Sensitivity Tests; Moxifloxacin; Mycobacterium; Mycobacterium Infections, Nontuberculous; Mycobacterium tuberculosis; Nontuberculous Mycobacteria; Tuberculosis	2022
Case report: A 9-year systematic treatment failure of a pulmonary tuberculosis patient. Frontiers in public health, 2022, Volume: 10 Topics: Amikacin; Antitubercular Agents; Capreomycin; Drug Resistance, Multiple, Bacterial; Humans; Microbial Sensitivity Tests; Moxifloxacin; Mycobacterium tuberculosis; Treatment Failure; Tuberculosis, Pulmonary	2022
In silico evaluation of WHO-endorsed molecular methods to detect drug resistant tuberculosis. Scientific reports, 2022, 10-22, Volume: 12, Issue:1 Topics: Amikacin; Antitubercular Agents; Capreomycin; Genotype; Humans; Isoniazid; Levofloxacin; Microbial Sensitivity Tests; Moxifloxacin; Mycobacterium tuberculosis; Pyrazinamide; Rifampin; Tuberculosis, Multidrug-Resistant; World Health Organization	2022
Towards clinical breakpoints for non-tuberculous mycobacteria - Determination of epidemiological cut off values for the Mycobacterium avium complex and Mycobacterium abscessus using broth microdilution. Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2023, Volume: 29, Issue:6 Topics: Amikacin; Anti-Bacterial Agents; Drug Resistance, Bacterial; Humans; Linezolid; Macrolides; Microbial Sensitivity Tests; Moxifloxacin; Mycobacterium abscessus; Mycobacterium avium; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Mycobacterium Infections, Nontuberculous; Mycobacterium tuberculosis; Nontuberculous Mycobacteria	2023
[Evaluation of Antimicrobial Susceptibilities of Rapidly Growing Mycobacteria]. Mikrobiyoloji bulteni, 2023, Volume: 57, Issue:2 Topics: Amikacin; Anti-Bacterial Agents; Cefoxitin; Ciprofloxacin; Clarithromycin; Doxycycline; Humans; Imipenem; Linezolid; Microbial Sensitivity Tests; Moxifloxacin; Mycobacterium; Mycobacterium Infections, Nontuberculous; Nontuberculous Mycobacteria; Tobramycin	2023
Genotypic and phenotypic comparison of drug resistance profiles of clinical multidrug-resistant Mycobacterium tuberculosis isolates using whole genome sequencing in Latvia. BMC infectious diseases, 2023, Sep-28, Volume: 23, Issue:1 Topics: Amikacin; Antitubercular Agents; Capreomycin; Drug Resistance, Multiple, Bacterial; Ethambutol; Ethionamide; Humans; Isoniazid; Kanamycin; Latvia; Microbial Sensitivity Tests; Moxifloxacin; Mycobacterium tuberculosis; Rifampin; Tuberculosis; Tuberculosis, Multidrug-Resistant; Whole Genome Sequencing	2023
Antimicrobial drug resistant features of Mycobacterium tuberculosis associated with treatment failure. PloS one, 2023, Volume: 18, Issue:10 Topics: Amikacin; Antitubercular Agents; Humans; Isoniazid; Linezolid; Microbial Sensitivity Tests; Moxifloxacin; Mutation; Mycobacterium tuberculosis; Pyrazinamide; Rifampin; Tuberculosis, Multidrug-Resistant; Verapamil	2023
Phenotypic drug-susceptibility profiles and genetic analysis based on whole-genome sequencing of Mycobacterium avium complex isolates in Thailand. PloS one, 2023, Volume: 18, Issue:11 Topics: Amikacin; Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Bacterial; Humans; Linezolid; Microbial Sensitivity Tests; Moxifloxacin; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Phylogeny; Thailand	2023